Erratum (DOI:10.1016/j.bbmt.2009.04.012);Toll-Like Receptor 4 Polymorphisms and Risk of Gram-Negative Bacteremia after Allogeneic Stem Cell Transplantation. A Prospective Pilot Study

Biology of Blood and Marrow Transplantation

Volumn 15, Issue 9, 2009, Pages 1130-1133

  Yaa, Mensah Nana ^a   Paolo, Peterlongo ^a   Peter, Steinherz ^a   Eric, Pamer G ^a   Jaya, Satagopan ^a   Papanicolaou, Genovefa Anna ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bone marrow transplantation; Gram negative infection; Innate immunity; Mutation; Polymorphism; Toll like receptor

Indexed keywords

ANTIBIOTIC AGENT; ASPARAGINE; GLYCINE; THREONINE; TOLL LIKE RECEPTOR 4;

ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CLINICAL TRIAL; GENE LOCUS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAM NEGATIVE SEPSIS; HETEROZYGOSITY; HUMAN; INCIDENCE; INFECTION RISK; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MORTALITY; NUCLEOTIDE SEQUENCE; PILOT STUDY; PROTEIN POLYMORPHISM; RISK ASSESSMENT;

EID: 67849115979     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2009.09.006     Document Type: Erratum

References (15)

1. Almyroudis N.G., Fuller A., Jakubowski A., et al. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients. Transpl Infect Dis 7 (2005) 11-17
2. Poltorak A., He X., Smirnova I., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
3. Arbour N.C., Lorenz E., Schutte B.C., et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25 (2000) 187-191
4. White S.N., Taylor K.H., Abbey C.A., Gill C.A., and Womack J.E. Haplotype variation in bovine Toll-like receptor 4 and computational prediction of a positively selected ligand-binding domain. Proc Natl Acad Sci USA 100 (2003) 10364-10369
5. Lorenz E., Mira J.P., Frees K.L., and Schwartz D.A. Relevance of mutations in the TLR4 receptor in patients with Gram-negative septic shock. Arch Intern Med 162 (2002) 1028-1032
6. Lorenz E., Frees K.L., and Schwartz D.A. Determination of the TLR4 genotype using allele-specific PCR. BioTechniques 31 (2001) 22-24
7. Torok H.P., Glas J., Tonenchi L., Mussack T., and Folwaczny C. Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. Clin Immunol 112 (2004) 85-91
8. Radstake T.R., Franke B., Hanssen S., et al. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Arthritis Rheum 50 (2004) 999-1001
9. Kiechl S., Lorenz E., Reindl M., et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347 (2002) 185-192
10. FineJp G.R. A proportional hazards model for the sub-distribution of a competing risk. J Am Stat Assoc 94 (1999) 496-509
11. Mullally A., and Ritz J. Beyond HLA: the significance of genomic variation for allogeneic hematopoietic stem cell transplantation. Blood 109 (2007) 1355-1362
12. Gereda J.E., Klinnert M.D., Price M.R., Leung D.Y., and Liu A.H. Metropolitan home living conditions associated with indoor endotoxin levels. J Allergy Clin Immunol 107 (2001) 790-796
13. Alexander C., and Rietschel E.T. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7 (2001) 167-202
14. Lorenz E., Schwartz D.A., Martin P.J., et al. Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 7 (2001) 384-387
15. Schoenfeld D.A. Sample-size formula for the proportional-hazards regression model. Biometrics 39 (1983) 499-503